Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does a 'biocompatible' peritoneal dialysis fluid improve survival compared with a standard fluid?

Nature Clinical Practice Nephrology volume 2, pages 14–15 (2006)Cite this article

boxed-textLee HY et al. (2005) Superior patient survival for continuous ambulatory peritoneal dialysis patients treated with a peritoneal dialysis fluid with neutral pH and low glucose degradation product concentration (Balance). Perit Dial Int 25: 248–255

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Witowski J et al. (2004) Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 19: 917–924

    Article  CAS  Google Scholar 

  2. Montenegro J et al. (2003) Important decrease of peritonitis incidence using new double-chamber bicarbonate solution on CAPD [abstract]. J Am Soc Nephrol 14: 480A

    Google Scholar 

  3. Rippe B et al. (2001) Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 59: 348–357

    Article  CAS  Google Scholar 

  4. Williams JD et al. (2004) The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66: 408–418

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Chief of the Nephrology Service at the Hospital de Galdakao, Bilbao, Spain

    Jesús Montenegro

Authors
  1. Jesús Montenegro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jesús Montenegro.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Montenegro, J. Does a 'biocompatible' peritoneal dialysis fluid improve survival compared with a standard fluid?. Nat Rev Nephrol 2, 14–15 (2006). https://doi.org/10.1038/ncpneph0074

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneph0074

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing